X0306 4 2021-07-16 0 0001752828 Celularity Inc CELU 0001869583 Beers David C C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 3.70 2021-07-16 4 A 0 538015 0.00 A 2031-07-16 Class A Common Stock 538015 538015 D Stock Option (Right to Buy) 10.21 2021-07-16 4 A 0 76859 0.00 A 2031-07-16 Class A Common Stock 76859 76859 D This option shall vest and become exercisable over a period of four years from the Vesting Start Date, January 31, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the "Business Combination Agreement"), by and among GX Acquisition Corp. ("GX"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. ("Legacy Celularity"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to "Celularity Inc." This option is fully vested and exercisable. /s/ Keary Dunn, Attorney-in-Fact 2021-07-20